Benesic A and Gerbes AL
Drug-induced Liver Injury and individual cell models. Digestive Diseases (2015); 33(4) 2015

A, Leitl, A and Gerbes AL
Monocyte-derived hepatocyte-like cells for causality assessment of idiosyncratic drug-induced liver injury. Gut (2015) online first June 4 2015; Gut doi-10.1136: gutjnl-2015-309528

A, Rahm NL, Ernst S and Gerbes AL
Human monocyte-derived cells with individual hepatocyte characteristics: a novel tool for personalized in vitro studies. Laboratory Investigation (2012) 92, 926–936; doi:10.1038/labinvest.2012.64; published online 2 April 2012

Gerbes AL, Zoulim F, Tilg H, Dufour JF, Bruix J, Paradis V, Salem R, Peck-Radosavljevic M, Galle PR, Greten TF, Nault JC, Avila MA.
Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma. Gut 2018; 67:380-388.

Benesic A, Rotter I, Dragoi D, Weber S, Buchholtz M, Gerbes AL.
Development and validation of a test to identify drugs that cause idiosyncratic drug-induced liver injury. Clin Gastro Hep 2018; 16(9):1488-1494.e5.

Dragoi D, Benesic A, Pichler G, Kulak NA, Bartsch HS, Gerbes AL.
Proteomics analysis of Monocyte-Derived Hepatocyte-Like Cells Identifies Integrin Beta 3 as a Specific Biomarker for Drug-Induced Liver Injury by Diclofenac. Frontiers in Pharmacology 2018; Jul 4;9:699, doi: 10.3389/fphar.2018.00699

Weber S, Benesic A, Rotter I, Gerbes AL.
Early ALT response to corticosteroid treatment distinguishes idiosyncratic Drug-induced Liver Injury from Autoimmune Hepatitis. Liver International 2019, published. doi:10.1111/liv.14195

Benesic A, Jalal K, Gerbes AL.
Drug-Drug Combinations can Enhance Toxicity as shown by Monocyte-Derived Hepatocyte-like Cells from Patients with Idiosyncratic Drug-Induced Liver Injury. Toxicological Sciences 2019, in press.